Manufacturing

Articles

Using the capabilities of Pharma Waldhof, one of Aceto’s facilities in Düsseldorf, Germany, the company plans to provide customers with access to raw materials, tested products for pharmaceutical cell culture applications, and cell culture media ingredients. 

Aceto Expands Biopharmaceutical and Cell Culture Reagent Portfolio to Meet Customer Demand

Nova Biomedical added a Sample Retain Collector (SRC) to its FLEX2 cell culture analyzer, which works to measure up to 16 tests including pH, gases, metabolites, osmolality, cell density, and cell viability. 

Cell Culture Analyzer with Sample Retain Collector

The new facility, which will be operated by Fujifilm Diosynth Biotechnologies, will provide large-scale cell-culture manufacturing of bulk drug substance with 8 x 20,000-L bioreactors.

Fujifilm to Invest Over $2 Billion into US Biopharmaceutical Manufacturing Facility  

Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA. 

Samsung Biologics Incorporates Solentim’s Cell Line Development Technology into New R&D Center 

Mogrify’s new technology platform, EpiMOGRIFY, can predict cellular switches important for determining cell identity, cell maintenance, directed differentiation, and cell conversion.

New EpiMOGRIFY Technology Platform Offers Development Support for Allogeneic Cell Therapies

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Biological and analytical advances enable modern fermentation processes to deliver safe and effective next-generation medicines.

Fermentation Finds Fans in Small-Molecule API Synthesis

The new VirusExpress lentiviral production platform increases dose yields and reduces process development time for cell and gene therapies.

MilliporeSigma Launches Lentiviral Production Platform for Cell and Gene Therapies

Feliza Mirasol is the science editor for 

The manufacture of gene therapy vectors is shifting to more modern technologies.

Modernizing Bioprocessing for Gene Therapy Viral Vectors

The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.

Cytiva Invests $500 Million Over 5 years to Expand Global Capacity

The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.

Manufacturing, Cell Culture and Fermentation